MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fonc.2026.1785566

Медицинская библиотека · Frontiers in oncology · 2026

Autologous and allogeneic hematopoietic cell transplantation in children and adults with high-risk anaplastic large cell lymphoma.

Smith Natalie L, Summers Corinne, Gooley Ted, Shustov Andrei, Salit Rachel, Gardner Rebecca A, Dahlberg Ann, Bleakley Marie, Sorror Mohamed L, Holmberg Leona, Carpenter Paul A, Sandmaier Brenda M, Maloney David, Thakar Monica S

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Both autologous and allogeneic hematopoietic cell transplantation (HCT) have been used to treat high-risk anaplastic large cell lymphoma (ALCL) that has failed conventional chemotherapy. However, many patients are not able to fully eradicate disease prior to HCT, making the role of either form of HCT unclear. The aim of this study was to collect characteristics and outcomes of patients who underwent either autologous and/or allogeneic HCT and determine the role that disease status at HCT plays in overall survival (OS).

METHODS

To address this, we collected data on 41 patients with ALCL that underwent autologous (n=24) and/or allogeneic (n=17) HCT at our center between 1997-2020.

RESULTS

The 5-year estimated progression-free survival (PFS) and OS for the autologous HCT group was 40% (95% confidence interval, 20-59%) and 53% (31-71%), while for the allogeneic HCT group it was 65% (38-92%) and 65% (38-82%), respectively. For transplants performed in 2009 or later, 5-year OS was 91% (51-99%) in the allogeneic HCT group, and 51% (23-73%) in the autologous HCT group. Notable was that for those who entered transplant with detectable disease, 5-year OS was 50% (15-77%) with allogeneic HCT whereas it was 27% (7-54%) for autologous HCT.

DISCUSSION: These data confirm that HCT is a potentially curative therapy, and allogeneic HCT may have a survival advantage over autologous HCT when there is detectable disease prior to HCT.

Для цитирования: Smith Natalie L, Summers Corinne, Gooley Ted, Shustov Andrei, Salit Rachel, Gardner Rebecca A, Dahlberg Ann, Bleakley Marie, Sorror Mohamed L, Holmberg Leona, Carpenter Paul A, Sandmaier Brenda M, Maloney David, Thakar Monica S. Autologous and allogeneic hematopoietic cell transplantation in children and adults with high-risk anaplastic large cell lymphoma.. Frontiers in oncology. 2026. DOI: 10.3389/fonc.2026.1785566.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.